PharmaCyte Biotech’s Live-Cell Encapsulation Facility is Commissioned for GMP Manufacture
April 25, 2016 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., April 25, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech’s Encapsulation Facility for Pancreatic Cancer Therapy Deemed Suitable by Thai FDA
April 08, 2016 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., April 08, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Finalizes Design of Pancreatic Cancer Clinical Trial and Identifies Trial Sites under Consideration
March 31, 2016 09:20 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., March 31, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and...
PharmaCyte Biotech Discusses Protection Strategy for Cancer and Diabetes Therapies
March 15, 2016 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., March 15, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes...
PharmaCyte Biotech Reports on Audit of Live-Cell Encapsulation Facility by Chamow & Associates
March 03, 2016 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., March 03, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and...
PharmaCyte Biotech Addresses Development of Targeted Cannabinoid Chemotherapy
March 01, 2016 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., March 01, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
PharmaCyte Biotech Pancreatic Cancer Treatment to Target Recently Identified Forms of Pancreatic Cancer
February 26, 2016 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Feb. 26, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech on Schedule for 2016 Cancer Clinical Trial in Pancreatic Cancer
February 24, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Feb. 24, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Issues Update on Preparations for Its Pancreatic Cancer Clinical Trial
February 22, 2016 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Feb. 22, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
Stonegate Capital Partners Publishes Research Report on PharmaCyte Biotech
February 10, 2016 09:32 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Feb. 10, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...